Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

Share Price is delayed by 15 minutes
Get Live Data
1,289.20    -22.20 (-1.69%)
Bid:
1,289.00
Ask:
1,289.40
Spread: 0.40 (0.031%)
Market Cap: £221.07b
HSBA Live PriceLast checked at - London Stock Exchange

Intraday HSBC Holdings Share Chart

Changes to Board and Committee Composition

11 Nov 2025 07:00

RNS Number : 9607G
HSBC Holdings PLC
10 November 2025
 

 

10 November 2025

HSBC HOLDINGS PLC

CHANGES TO BOARD AND COMMITTEE COMPOSITION

 

HSBC Holdings plc ('HSBC' or the 'Company') has today announced the appointment of Wei Sun Christianson (aged 69) as an Independent non-executive Director and member of the Group Risk Committee and the Nomination and Corporate Governance Committee with effect from 1 January 2026.

 

Wei Sun brings extensive banking and regulatory experience gained over a 30-year international career. Wei Sun most recently served as a Senior Advisor at Morgan Stanley, a role she assumed following her retirement from Morgan Stanley in 2022. Her final executive role at Morgan Stanley was Co-CEO, Asia Pacific and she also served as CEO, Morgan Stanley China from 2006 to 2022.

 

Prior to Morgan Stanley, she held senior regulatory roles at the Hong Kong Securities and Futures Commission where she was involved in the drafting of the regulatory structure that would enable the companies of the People's Republic of China to be listed outside China.

 

In line with the UK and Hong Kong Corporate Governance Codes, the Board have determined that Wei Sun is independent. In making that determination, the Board have concluded that there are no other relationships or circumstances which are likely to affect her judgements and that any relationships or circumstances which could appear to do so are not considered to be material.

 

Commenting on the appointment, HSBC's Group Chair, Brendan Nelson, said:

 

"Wei Sun is a highly regarded and experienced business leader, with deep banking knowledge and experience in HSBC's strategically important markets, including Hong Kong and Mainland China. This experience will be an asset to the Board. We look forward to welcoming her to the Board in the new year."

 

 

For and on behalf of

HSBC Holdings plc

 

Aileen Taylor

Company Secretary

 

 

Media enquiries to:

Neil Fleming +44 (0) 7384 792051 neil1.fleming@hsbc.com

 

 

 

Supplementary Information:

Wei Sun's appointment as a Director of the Company is subject to election by shareholders at the 2026 Annual General Meeting ('AGM') and annual re-election thereafter. Her initial three-year term will run from her initial election, if successful, until the 2029 AGM.

 

As an Independent non-executive Director, Wei Sun will not have a service contract with the Company and will be paid total fees of £213,150 per annum pursuant to the Directors' remuneration policy, approved by shareholders at the 2025 AGM. The total per annum fees consists of: £136,500 for her role as Independent non-executive Director, £42,000 for her role as a member of the Group Risk Committee and £34,650 for her role as a member of the Nomination and Corporate Governance Committee.

 

Professional qualifications: Juris Doctor, Columbia University School of Law, Bachelor of Arts in Political Science, Amherst College and a member of the New York Bar Association.

 

Current and past listed company appointments:

· Independent non-executive director of LVMH Moët Hennessy Louis Vuitton SE: 18 April 2024 - Present.

· Independent non-executive director of The Estée Lauder Companies Inc: 1 March 2011 - 17 November 2023.

 

Save as disclosed above, Wei Sun has not held any directorships in any other publicly listed companies, whether in London, Hong Kong or overseas, during the previous five years. She does not have any relationship with any directors, senior management, substantial or controlling shareholders of the Company.

 

Wei Sun has confirmed:

· Her respective independence as regards each of the factors referred to in Rule 3.13(1) to (8) of the Hong Kong Listing Rules;

· she does not have any past or present financial or other interest in the business of the Company or its subsidiaries or any connection with any core connected person of the Company;

· she does not have any interests in the shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance; and

· that there are no other factors that may affect her independence at the time of her appointment.

 

There are no matters that need to be disclosed pursuant to Listing Rule 6.4.8(1) to (6) of the Listing Rules of the Financial Conduct Authority. Save as disclosed above there is no other information required to be disclosed pursuant to Rule 13.51(2) of the Rules Governing the Listing of Securities on the Stock Exchange of the Hong Kong Limited.

 

 

 

HSBC Holdings plc

Registered Office and Group Head Office:

8 Canada Square, London E14 5HQ, United Kingdom

Web: www.hsbc.com

Incorporated in England and Wales with limited liability. Registration number 617987.

 

Board of Directors

The Board of Directors of HSBC Holdings plc as at the date of this announcement comprises:

Brendan Robert Nelson*, Georges Bahjat Elhedery, Geraldine Joyce Buckingham†, Rachel Duan†, Dame Carolyn Julie Fairbairn†, James Anthony Forese†, Ann Frances Godbehere†, Steven Craig Guggenheimer†, Manveen (Pam) Kaur, Dr José Antonio Meade Kuribreña†, Kalpana Jaisingh Morparia†, Eileen K Murray† and Swee Lian Teo†.

*  Independent non-executive Chair

  Independent non-executive Director

 

HSBC Group

HSBC Holdings plc, the parent company of HSBC, is headquartered in London. HSBC serves customers worldwide from offices in 57 countries and territories. With assets of US$3,234bn at 30 September 2025, HSBC is one of the world's largest banking and financial services organisations.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAFFEFEPSFAA
Date   Source Headline
2nd Jun 20262:41 pmRNSHolding(s) in Company
29th May 20264:01 pmRNSTotal Voting Rights
29th May 20264:00 pmRNSNotification of issuance under block listing
27th May 20264:00 pmRNSDirector/PDMR Shareholding
26th May 20261:30 pmRNSIssuance of senior unsecured notes
21st May 20267:00 amRNSHSBC investor and analyst Asia seminar
20th May 20267:00 amRNSHSBC investor and analyst Asia seminar
18th May 20264:20 pmRNSIssuance of perpetual subordinated CC securities
15th May 202611:00 amRNSNotice of redemption and cancellation of listing
12th May 20264:40 pmRNSIssuance of senior unsecured notes (USD)
12th May 20264:05 pmRNSIssuance of senior unsecured notes
12th May 20267:00 amRNSIssuance of perpetual subordinated CCS
8th May 20262:15 pmRNSResult of AGM
8th May 202610:03 amRNSAGM Statements
7th May 202610:30 amRNSOverseas Regulatory Announcement - Grant of Awards
6th May 202610:00 amRNSBoard and Committee Composition
5th May 202612:30 pmRNSPublication of base prospectus supplement
5th May 20267:00 amRNSEarnings Release 1Q26 Zoom Meeting
5th May 20267:00 amRNSEarnings Release 1Q26
1st May 20264:00 pmRNSDirector/PDMR Shareholding
30th Apr 20263:01 pmRNSTotal Voting Rights
30th Apr 20263:00 pmRNSNotification of issuance under block listing
28th Apr 20269:51 amRNSHolding(s) in Company
23rd Apr 202610:00 amRNSNotice of redemption & cancellation of listing
22nd Apr 202610:00 amRNSOverseas Regulatory Announcement - Board Meeting
20th Apr 202612:45 pmRNSFourth Interim Dividend for 2025 - Exchange Rate
17th Apr 20267:00 amRNSAmended and Restated Notice of Redemption
16th Apr 20262:30 pmRNSNotice of redemption
16th Apr 20269:02 amRNSHolding(s) in Company
14th Apr 202610:30 amRNSOverseas Regulatory Announcement - Grant of Awards
30th Mar 20265:01 pmRNSTotal Voting Rights
30th Mar 20265:00 pmRNSNotification of issuance under block listing
30th Mar 20264:40 pmRNSPublication of base prospectus
27th Mar 20261:30 pmRNSIssuance of senior unsecured notes
27th Mar 20269:00 amRNS2026 AGM - Documents available at NSM
26th Mar 20264:00 pmRNSDirector/PDMR Shareholding
25th Mar 20269:30 amRNSHong Kong Waiver-Contingent Convertible Securities
24th Mar 20264:30 pmRNSDirector/PDMR Shareholding
24th Mar 20263:50 pmRNSIssuance of contingent convertible securities
20th Mar 202611:35 amRNSHolding(s) in Company
20th Mar 202610:56 amRNSHolding(s) in Company
18th Mar 20265:13 pmRNSHolding(s) in Company
18th Mar 20267:00 amRNSPam Kaur speaks at Investor Conference
18th Mar 20267:00 amRNSIssuance of contingent convertible securities
16th Mar 20269:23 amRNSHolding(s) in Company
16th Mar 20269:23 amRNSHolding(s) in Company
13th Mar 20264:00 pmRNSDirector/PDMR Shareholding
12th Mar 20264:24 pmRNSHolding(s) in Company
12th Mar 20269:00 amRNSGroup reporting changes
12th Mar 20269:00 amRNSGroup reporting changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.